Atrial cardiopathy: A broadened concept of left atrial thromboembolism beyond atrial fibrillation

Future Cardiology

Volumn 11, Issue 3, 2015, Pages 323-331

  Kamel, Hooman ^a   Okin, Peter M ^b   Longstreth, W T ^c   Elkind, Mitchell S V ^d   Soliman, Elsayed Z ^e  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Wake Forest University ^*  (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

arrhythmia; atrial abnormality; atrial cardiopathy; atrial fibrillation; atrial substrate; cardiac embolism; cerebrovascular disease; embolic stroke; stroke

Indexed keywords

ATRIAL CARDIOPATHY; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; GENETIC DISORDER; HEART ATRIUM ENLARGEMENT; HEART DISEASE; HUMAN; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM; ANIMAL; COMPLICATION; HEART ATRIUM; PATHOPHYSIOLOGY;

ANTICOAGULANT AGENT;

ANIMALS; ANTICOAGULANTS; ATRIAL FIBRILLATION; HEART ATRIA; HUMANS; RISK FACTORS; THROMBOEMBOLISM;

EID: 84930365699     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.15.22     Document Type: Review

References (59)

1. Chugh SS, Havmoeller R, Narayanan K et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129, 837-847 (2014
2. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285, 2370-2375 (2001
3. Yiin GSC, Howard DPJ, Paul NLM et al. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation 130, 1236-1244 (2014
4. Lin HJ, Wolf PA, Kelly-Hayes M et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27, 1760-1764 (1996
5. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Pujades R, Targa C. Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction. Int. J. Cardiol. 73, 33-42 (2000
6. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ of An Emerging Epidemic: An Economic Analysis of Atrial Fibrillation in the UK. Heart 90, 286-292 (2004
7. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonvalvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst. Rev. CD006186 (2007
8. Ruff CT, Giugliano RP, Braunwald E et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383, 955-962 (2014
9. Connolly SJ, Eikelboom J, Joyner C et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 364, 806-817 (2011
10. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr. Cardiol. Rev. 6, 150-161 (2010
11. Ziegler PD, Glotzer TV, Daoud EG et al. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke 41, 256-260 (2010
12. Healey JS, Connolly SJ, Gold MR et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366, 120-129 (2012
13. Marnane M, Duggan CA, Sheehan OC et al. Stroke subtype classification to mechanismspecific and undetermined categories by TOAST, A-S-C-O, and Causative Classification system. Stroke 41, 1579-1586 (2010
14. Hart RG, Diener HC, Coutts SB et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 13, 429-438 (2014
15. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 2160-2236 (2014
16. Kishore A, Vail A, Majid A et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke 45, 520-526 (2014
17. Gladstone DJ, Spring M, Dorian P et al. Atrial fibrillation in patients with cryptogenic stroke. N. Engl. J. Med. 370, 2467-2477 (2014
18. Sanna T, Diener HC, Passman RS et al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 370, 2478-2486 (2014
19. Brambatti M, Connolly SJ, Gold MR et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 129, 2094-2099 (2014
20. Cai H, Li Z, Goette A et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106, 2854-2858 (2002
21. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96, 1180-1184 (1997
22. Mihm MJ, Yu F, Carnes CA et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104, 174-180 (2001
23. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89, 724-730 (1994
24. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121, 1904-1911 (2010
25. Kamel H, Elkind MS, Bhave PD et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke 44, 1550-1554 (2013
26. Todo K, Moriwaki H, Saito K, Naritomi H. Frequent premature atrial contractions in stroke of undetermined etiology. Eur. Neurol. 61, 285-288 (2009
27. Morris JJ Jr, Estes EH Jr, Whalen RE, Thompson HK Jr, McIntosh HD. P-wave analysis in valvular heart disease. Circulation 29, 242-252 (1964
28. Alpert MA, Munuswamy K. Electrocardiographic diagnosis of left atrial enlargement. Arch. Intern. Med. 149, 1161-1165 (1989
29. Goyal SB, Spodick DH. Electromechanical dysfunction of the left atrium associated with interatrial block. Am. Heart. J. 142, 823-827 (2001
30. Scott CC, Leier CV, Kilman JW, Vasko JS, Unverferth DV. The effect of left atrial histology and dimension on P wave morphology. J. Electrocardiol. 16, 363-366 (1983
31. Kamel H, Soliman EZ, Heckbert SR et al. P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke 45, 2786-2788 (2014
32. Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR. Electrocardiographic left atrial abnormalities and risk of ischemic stroke. Stroke 36, 2481-2483 (2005
33. Kamel H, Bartz TM, Longstreth WT Jr et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke 46, 711-716 (2015
34. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the atherosclerosis risk in communities (ARIC) study. Stroke 40, 1204-1211 (2009
35. Karas MG, Devereux RB, Wiebers DO et al. Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke 43, 720-726 (2012
36. Barnes ME, Miyasaka Y, Seward JB et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin. Proc. 79, 1008-1014 (2004
37. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 30, 2019-2024 (1999
38. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The framingham heart study. Circulation 92, 835-841 (1995
39. Russo C, Jin Z, Liu R et al. La volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc. Imaging 6, 313-323 (2013
40. Folsom AR, Nambi V, Bell EJ et al. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke 44, 961-967 (2013
41. Cushman M, Judd SE, Howard VJ et al. N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke 45, 1646-1650 (2014
42. Stoyanov N, Winterfield J, Varma N, Gollob MH. Atrial arrhythmias in the young: early onset atrial arrhythmias preceding a diagnosis of a primary muscular dystrophy. Europace 16, 1814-1820 (2014
43. Buckley AE, Dean J, Mahy IR. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82, 105-108 (1999
44. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453-1468 (2014
45. Gallagher MM, Obel OA, Camm JA. Tachycardia-induced atrial myopathy: an important mechanism in the pathophysiology of atrial fibrillation?J. Cardiovasc. Electrophysiol. 8, 1065-1074 (1997
46. De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc. Res. 89, 754-765 (2011
47. Pathak RK, Middeldorp ME, Lau DH et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J. Am. Coll. Cardiol. 64, 2222-2231 (2014
48. Disertori M, Quintarelli S, Grasso M et al. Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. Circ. Cardiovasc. Genet. 6, 27-36 (2013
49. Chao TF, Liu CJ, Chen SJ et al Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?. Stroke 43, 2551-2555 (2012
50. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137, 263-272 (2010
51. Al-Khatib SM, Allen LaPointe NM, Chatterjee R et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann. Intern. Med. 160, 760-773 (2014
52. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the framingham study. Stroke 14, 664-667 (1983
53. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 80, 1546-1550 (2013
54. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke 41, 1514-1520 (2010
55. Kamel H, Navi BB, Elijovich L et al. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke 44, 528-530 (2013
56. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 127, 930-937 (2013
57. Lovett KM, Liang BA. Direct-to-consumer cardiac screening and suspect risk evaluation. JAMA 305, 2567-2568 (2011
58. Longstreth WT Jr, Kronmal RA, Thompson JL et al. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke 44, 714-719 (2013
59. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380, 2095-2128 (2012